81 related articles for article (PubMed ID: 19289366)
1. Targeted therapy in lung cancer: the good, the bad, and the ugly.
Gadgeel SM
Clin Lung Cancer; 2009 Jan; 10(1):10-2. PubMed ID: 19289366
[No Abstract] [Full Text] [Related]
2. The current status of targeted therapy for non-small cell lung cancer.
Francis H; Solomon B
Intern Med J; 2010 Sep; 40(9):611-8. PubMed ID: 20002849
[TBL] [Abstract][Full Text] [Related]
3. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
Langer C; Soria JC
Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer].
Zhou CC; Deng XF
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):138-40. PubMed ID: 17445479
[No Abstract] [Full Text] [Related]
5. [Biological therapy in non-small-cell lung cancer (NSCLC)].
Souquet PJ
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S53-4S56. PubMed ID: 15687996
[No Abstract] [Full Text] [Related]
6. The evolving story of the epidermal growth factor receptor as a target for non-small-cell lung cancer.
Lynch TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):786-7. PubMed ID: 16166955
[No Abstract] [Full Text] [Related]
7. Targeted therapy for non-small cell lung cancer.
Toloza EM; D'Amico TA
Semin Thorac Cardiovasc Surg; 2005; 17(3):199-204. PubMed ID: 16253823
[TBL] [Abstract][Full Text] [Related]
8. Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
Gridelli C; Massarelli E; Maione P; Rossi A; Herbst RS; Onn A; Ciardiello F
Cancer; 2004 Oct; 101(8):1733-44. PubMed ID: 15386339
[TBL] [Abstract][Full Text] [Related]
9. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
10. [Current status of the study of the mechanism of epidermal growth factor receptor targeting drug therapy and their related markers].
Wang Y; Xu JM; Song ST
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):573-6. PubMed ID: 16438862
[No Abstract] [Full Text] [Related]
11. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Cascone T; Gridelli C; Ciardiello F
Curr Opin Oncol; 2007 Mar; 19(2):98-102. PubMed ID: 17272980
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies and non-small-cell lung cancer: work in progress?
Gridelli C
Curr Opin Oncol; 2006 Mar; 18(2):132-4. PubMed ID: 16462181
[No Abstract] [Full Text] [Related]
13. First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?
Gridelli C
Curr Opin Oncol; 2011 Mar; 23(2):131-2. PubMed ID: 21307676
[No Abstract] [Full Text] [Related]
14. Targeted therapies in lung cancer: a tribute to advancements in clinical research.
McGee L
ONS Connect; 2007; 22(8 Suppl):27-8. PubMed ID: 17824552
[No Abstract] [Full Text] [Related]
15. [Is it necessary to select patients to prescribe targeted therapies in stage IV non-small-cell lung cancers?].
Cadranel J
Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S41-4. PubMed ID: 17404539
[No Abstract] [Full Text] [Related]
16. Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand.
Lopes Gde L
IDrugs; 2009 Nov; 12(11):689-91. PubMed ID: 19844853
[TBL] [Abstract][Full Text] [Related]
17. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Kotsakis A; Georgoulias V
Expert Opin Pharmacother; 2010 Oct; 11(14):2363-89. PubMed ID: 20586711
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies and non-small-cell lung cancer: new developments.
Gridelli C
Curr Opin Oncol; 2007 Mar; 19(2):75-7. PubMed ID: 17272976
[No Abstract] [Full Text] [Related]
19. Complex role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer.
Neal JW; Sequist LV
J Clin Oncol; 2012 Jun; 30(18):2280-2. PubMed ID: 22508823
[No Abstract] [Full Text] [Related]
20. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
Maione P; Gridelli C; Troiani T; Ciardiello F
Oncologist; 2006 Mar; 11(3):274-84. PubMed ID: 16549812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]